NF1 and juvenile myelomonocytic leukemia: Although it is not a common complication, NF1-mutated neurofibromatosis type 1 patients have an increased predisposition to develop JMML, with a 200- to 350-fold increased risk compared to their wild type NF1 counterparts [4].